Table 1.
Clinicopathological data from reported cases of solitary splenic metastasis arising from gastric cancer
| Author | Age | Gender | Primary gastric cancer | Splenic metastasis | Outcome | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tumor location | Tumor size (cm) | Gross appearance type | Tumor depth | Lymph node involvement | Histological type | Treatment | Tumor size (cm) | Treatment | Histological type | Duration (months) | ||||
| Yamanouchi [6] | 65 | Male | L | ND | Ulcerated | ss | Positive | Intestinal | DG | 4.5 | Splenectomy | Intestinal | 50 | DOD at 40 months |
| Kawasaki [7] | 75 | Male | U | 2.0 | Elevated | sm | Positive | Intestinal | EMR, PG | 6.5 | Chemotherapy, Splenectomy | Intestinal | 14 | 2 years survival |
| Deng [8] | 49 | Male | M | 6.0 | ND | se | Positive | Intestinal | DG | 14 | Splenectomy | Diffuse | 60 | 9 months survival |
| Present case | 77 | Male | U | 2.2 | Elevated | sm | Negative | Intestinal | ESD, TG | 5.5 | Splenectomy | Diffuse | 28 | 2 months survival |
Abbreviations: DG distal gastrectomy, DOD dead of disease, EMR endoscopic mucosal resection, ESD endoscopic submucosal dissection, L lower-third of the stomach, M middle-third of the stomach, ND not described, PG proximal gastrectomy, se serosa, sm submucosa, ss subserosa, TG total gastrectomy, U upper-third of the stomach